Acura Pharmaceuticals Operating Income 2010-2021 | ACUR

Acura Pharmaceuticals operating income from 2010 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.

Acura Pharmaceuticals Operating Income 2010-2021 | ACUR

Acura Pharmaceuticals operating income from 2010 to 2021. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
Related Stocks
Company NameMarket
Cap
Teva Pharmaceutical Industries (TEVA)$15.5B
Dr Reddy's Laboratories (RDY)$11.4B
BridgeBio Pharma (BBIO)$6.4B
Bausch Health Cos (BHC)$1.9B
Supernus Pharmaceuticals (SUPN)$1.7B
Amphastar Pharmaceuticals (AMPH)$1.1B
Personalis (PSNL)$282M
Taysha Gene Therapies (TSHA)$254M
Assembly Biosciences (ASMB)$75M
Sol-Gel Technologies (SLGL)$15M
Evoke Pharma (EVOK)$3M
Teligent (TLGT)$0M